Profund Advisors’s ImmunityBio IBRX Stock Holding History

Profund Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.86M	Buy	243,008 +18,324	+8%	+$125K	0.07%	223
2025 Q4	$445K	Buy	224,684 +127,142	+130%	+$288K	0.01%	614
2025 Q3	$240K	Buy	97,542 +43,130	+79%	+$111K	0.01%	874
2025 Q2	$144K	Sell	54,412 -12,670	-19%	-$34.1K	0.01%	945
2025 Q1	$202K	Sell	67,082 -37,102	-36%	-$112K	0.01%	901
2024 Q4	$267K	Buy	104,184 +14,960	+17%	+$62.3K	0.01%	830
2024 Q3	$332K	Buy	89,224 +9,044	+11%	+$41.9K	0.01%	739
2024 Q2	$507K	Sell	80,180 -121,163	-60%	-$799K	0.02%	491
2024 Q1	$1.08M	Buy	201,343 +81,386	+68%	+$369K	0.04%	340
2023 Q4	$602K	Buy	+119,957	New	+$376K	0.03%	458

Other funds holding IBRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return